The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population.
All Keywords
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, quarantine, severe acute respiratory syndrome Coronavirus, Patient, Incubation period, Hypogammaglobulinemia, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, patient population, presymptomatic transmission, raise, 【제목키워드】 SARS-CoV-2, coronavirus, therapy, Patient, Prolonged, acute respiratory syndrome,
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, quarantine, severe acute respiratory syndrome Coronavirus, Patient, Incubation period, Hypogammaglobulinemia, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, patient population, presymptomatic transmission, raise, 【제목키워드】 SARS-CoV-2, coronavirus, therapy, Patient, Prolonged, acute respiratory syndrome,
중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2)의 잠복기는 거의 14일 이상입니다. 우리는 확인된 잠복기가 21일 이상인 2019년 코로나바이러스 질병(COVID-19)이 발생한 저감마글로불린혈증 환자를 보고합니다. 이러한 발견은 장기간의 무증상 전파 단계에 대한 우려를 불러일으키며, 이 환자 집단에서 더 긴 격리 기간을 필요로 합니다.